{"id":"https://openalex.org/W2903553882","doi":null,"title":"Analysing the eligibility of chemotherapy agents for dose-banding","display_name":"Analysing the eligibility of chemotherapy agents for dose-banding","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2903553882","mag":"2903553882"},"language":"en","primary_location":{"id":"mag:2903553882","doi":null,"is_oa":false,"landing_page_url":"https://dissem.in/p/93472671/analysing-the-eligibility-of-chemotherapy-agents-for-dose-banding","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049059992","display_name":"Heike Reinhardt","orcid":"https://orcid.org/0000-0002-5428-3881","observed_orcids":["https://orcid.org/0000-0002-5428-3881"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heike Reinhardt","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5428-3881","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036413141","display_name":"Rainer Trittler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rainer Trittler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112910025","display_name":"Stefan Woehrl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefan Woehrl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068118490","display_name":"Thomas Epting","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Epting","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033988421","display_name":"Meredith Buck","orcid":"https://orcid.org/0000-0002-5692-9367","observed_orcids":["https://orcid.org/0000-0002-5692-9367"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meredith Buck","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5692-9367","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Sabine Kaiser","orcid":"https://orcid.org/0000-0002-2081-7734","observed_orcids":["https://orcid.org/0000-0002-2081-7734"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sabine Kaiser","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2081-7734","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Daniel E Jonas","orcid":"https://orcid.org/0000-0003-1964-8731","observed_orcids":["https://orcid.org/0000-0003-1964-8731"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel E Jonas","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1964-8731","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088789978","display_name":"Justus Duyster","orcid":"https://orcid.org/0000-0001-7325-7753","observed_orcids":["https://orcid.org/0000-0001-7325-7753"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Justus Duyster","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7325-7753","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016266091","display_name":"Manfred Jung","orcid":"https://orcid.org/0000-0002-6361-7716","observed_orcids":["https://orcid.org/0000-0002-6361-7716"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manfred Jung","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6361-7716","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012552638","display_name":"Martin Johannes Hug","orcid":"https://orcid.org/0000-0003-2305-2746","observed_orcids":["https://orcid.org/0000-0003-2305-2746"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin J. Hug","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2305-2746","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5102316479","display_name":"M. Engelhardt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Engelhardt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.48540381,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13279","display_name":"Safe Handling of Antineoplastic Drugs","score":0.6538000106811523,"subfield":{"id":"https://openalex.org/subfields/3609","display_name":"Occupational Therapy"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13279","display_name":"Safe Handling of Antineoplastic Drugs","score":0.6538000106811523,"subfield":{"id":"https://openalex.org/subfields/3609","display_name":"Occupational Therapy"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.10480000078678131,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.050700001418590546,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chemotherapy-agents","display_name":"chemotherapy agents","score":0.7390000224113464},{"id":"https://openalex.org/keywords/dose-banding","display_name":"dose banding","score":0.8640000224113464},{"id":"https://openalex.org/keywords/eligibility-determination","display_name":"eligibility determination","score":0.4959999918937683},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.40799999237060547},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4394078850746155},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3407561480998993},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13415732979774475}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2903553882","doi":null,"is_oa":false,"landing_page_url":"https://dissem.in/p/93472671/analysing-the-eligibility-of-chemotherapy-agents-for-dose-banding","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8199999928474426}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W313298948","https://openalex.org/W2103766921","https://openalex.org/W6903844108","https://openalex.org/W2290545614","https://openalex.org/W2768470642","https://openalex.org/W2060226214","https://openalex.org/W2291924958","https://openalex.org/W1943928227","https://openalex.org/W4298173228","https://openalex.org/W3023844016"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2018-12-11T00:00:00"}